Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.86 | 08:29:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.86 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.11 - 3.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.86 | USD |
ProQR Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 151.32M | 81.35M | - | 6.59M | -28.12M | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProQR Therapeutics NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRQR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.23 | 2.31 | 1.81 | 2.00 | 208,128 | -0.37 | -16.59% |
| 1 Month | 2.37 | 2.49 | 1.81 | 2.17 | 158,428 | -0.51 | -21.52% |
| 3 Months | 2.06 | 2.70 | 1.81 | 2.14 | 211,678 | -0.20 | -9.71% |
| 6 Months | 1.30 | 3.29 | 1.11 | 2.04 | 259,603 | 0.56 | 43.08% |
| 1 Year | 2.15 | 3.29 | 1.11 | 1.88 | 269,352 | -0.29 | -13.49% |
| 3 Years | 5.95 | 9.09 | 0.53 | 2.85 | 818,029 | -4.09 | -68.74% |
| 5 Years | 11.24 | 13.28 | 0.53 | 4.53 | 747,090 | -9.38 | -83.45% |
ProQR Therapeutics NV Description
| ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. |
